Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) Net Margin (2016 - 2025)

Historic Net Margin for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to 19.22%.

  • Orthopediatrics' Net Margin fell 47100.0% to 19.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.06%, marking a year-over-year decrease of 50600.0%. This contributed to the annual value of 18.47% for FY2024, which is 43700.0% down from last year.
  • Per Orthopediatrics' latest filing, its Net Margin stood at 19.22% for Q3 2025, which was down 47100.0% from 11.65% recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Net Margin peaked at 53.04% during Q3 2022, and registered a low of 48.36% during Q1 2021.
  • Its 5-year average for Net Margin is 14.01%, with a median of 14.51% in 2024.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 743400bps in 2021, then plummeted by -645300bps in 2023.
  • Over the past 5 years, Orthopediatrics' Net Margin (Quarter) stood at 0.29% in 2021, then tumbled by -8826bps to 25.32% in 2022, then increased by 30bps to 17.79% in 2023, then tumbled by -72bps to 30.51% in 2024, then soared by 37bps to 19.22% in 2025.
  • Its last three reported values are 19.22% in Q3 2025, 11.65% for Q2 2025, and 20.34% during Q1 2025.